The Effect of Certolizumab on Lower Extremity Lymph Flow in Rheumatoid Arthritis
Phase of Trial: Phase IV
Latest Information Update: 22 Sep 2015
At a glance
- Drugs Certolizumab pegol (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 07 Apr 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 10 Jan 2014 Status changed from recruiting to active, no longer recruiting.
- 27 Jul 2012 Planned End Date changed from 1 May 2012 to 1 May 2014 as reported by ClinicalTrials.gov.